Your browser doesn't support javascript.
loading
[Jinghuaweikang capsules combined with Quadruple therapy in the treatment of Helicobacter pylori infection:a multicenter,randomized,controlled,clinical study].
Yang, Q; Shang, Q; Wei, G Q; Guo, Q H; Ka, S Q; Zhang, Z Y; Li, F W; Shen, X P; Zhang, D K.
Afiliación
  • Yang Q; Department of Gastroenterology, Xigu Hospital of Lanzhou University Second Hospital, Lanzhou 730000, China.
  • Shang Q; Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730000, China.
  • Wei GQ; Department of Gastroenterology, Jiugang Hospital, Jiayuguan 735100, China.
  • Guo QH; Department of Gastroenterology, the First Hospital of Lanzhou University, Lanzhou 730000, China.
  • Ka SQ; Department of Gastroenterology, the First People's Hospital of Lanzhou City, Lanzhou 730000, China.
  • Zhang ZY; Department of Gastroenterology, Gansu Wuwei Tumor Hospital, Wuwei 733000, China.
  • Li FW; Department of Gastroenterology, the First People's Hospital of Baiyin, Baiyin 730900, China.
  • Shen XP; School of Public Health, Lanzhou University, Lanzhou 730000, China.
  • Zhang DK; Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730000, China.
Zhonghua Yi Xue Za Zhi ; 99(4): 295-300, 2019 Jan 22.
Article en Zh | MEDLINE | ID: mdl-30669717

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Helicobacter pylori / Infecciones por Helicobacter Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans / Male Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Helicobacter pylori / Infecciones por Helicobacter Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans / Male Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2019 Tipo del documento: Article País de afiliación: China